The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phentermine HCL C-IV
Phentermine HCL C-IV · PHENTERMINE HYDROCHLORIDE 15 mg/1 · Capsule · Oral · Direct_Rx
NDC 72189-0365-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Direct RxUnited Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA205019
- TE code
- AA
- Approval date
- Dec 5, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Phentermine HCL C-IV (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Direct_Rx | PHENTERMINE HYDROCHLORIDE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phentermine HCL C-IV — NDC 72189-0365-30," retrieved September 3, 2026, https://drugdashboards.com/drug/72189036530.
Free to cite with attribution — see how the data is put together.